SERMS Selective Estrogen Receptor Modulators Raloxifene (Evista®) is from a family of drugs called SERMs (Selective Estrogen Receptor Modulators). How Does Raloxifene Work? During their reproductive years, women produce significant […]

The recent study by Bolland and colleagues published in the Lancet Diabetes Endocrinology (Oct 4, 2018) is an updated meta-analysis that evaluated the effects of vitamin D supplementation on fractures, […]

Osteoporosis Canada (OC) is excited to announce the upcoming launch of the OC FLS Registry. The OC FLS Registry will be an online map profiling FLS programs across Canada, which meet OC’s Essential […]

The pilot announced by the Canadian Celiac Association has been officially extended until March 31, 2024 and allows Ontario residents to be screened for celiac disease among other tests at […]

Christine Thomas was only 42 when, bending to lift her newborn daughter, she fractured her spine. Diagnosed with five vertebral fractures as a result of unsuspected osteoporosis, she had no idea of the painful and transformative road she would have to travel to build stronger bones and reclaim her life.

Great Giving Challenge You Could Win $20,000 for Osteoporosis Canada! The Great Canadian Giving Challenge is a month-long initiative to help us raise much needed funds to support the over […]

Closing the post-fracture care gap for the patients at Peace Arch Hospital (White Rock, British Columbia) has been a long-time dream for Dr. Sonia Singh. As a family physician who […]

Osteoporosis Canada helps educate Canadians on the importance of bone health and improve the quality of life for those diagnosed with osteoporosis. Many supporters of Osteoporosis Canada find peace of […]

Research Competition The Osteoporosis Research Program provides training awards to support Canadian investigators conducting research that promises to yield new insights into the prevention and treatment of osteoporosis and improving […]